• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFR14A filed by Horizon Technology Finance Corporation

    5/15/25 4:29:58 PM ET
    $HRZN
    Finance: Consumer Services
    Finance
    Get the next $HRZN alert in real time by email
    DEFR14A 1 hrzn20250514_defr14a.htm FORM DEFR14A hrzn20250514_defr14a.htm

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 14A

     

    Proxy Statement Pursuant to Section 14(a) of

    the Securities Exchange Act of 1934

    (Amendment)

     

    Filed by the Registrant ☑

     

    Filed by a Party other than the Registrant ☐

     

    Check the appropriate box:

     

    ☐

    Preliminary Proxy Statement

    ☐

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

    ☑

    Definitive Proxy Statement

    ☐

    Definitive Additional Materials

    ☐

    Soliciting Material under §240.14a-12

     

    Horizon Technology Finance Corporation

    (Name of Registrant as Specified in Its Charter)

     

    (Name of Person(s) Filing Proxy Statement if Other Than the Registrant)

     

    Payment of Filing Fee (Check the appropriate box):

     

    ☑

    No fee required

    ☐

    Fee paid previously with preliminary materials

    ☐

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

     

     

     

     

    HORIZON TECHNOLOGY FINANCE CORPORATION
    312 Farmington Avenue
    Farmington, Connecticut 06032
    (860) 676-8654

    AMENDMENT TO

    PROXY STATEMENT
    For
    2025 Annual Meeting of Stockholders
    To Be Held on June 5, 2025

     

     

    EXPLANATORY NOTE

     

    On April 17, 2025, Horizon Technology Finance Corporation (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a definitive proxy statement on Schedule 14A for its 2025 Annual Meeting of Stockholders (the “Proxy Statement”). This Amendment to Proxy Statement on Schedule 14A (this “Amendment”) is being filed to amend the Proxy Statement for the 2025 Annual Meeting of Stockholders to update the disclosures provided in “PROPOSAL 1: ELECTION OF DIRECTORS” beginning on page 6 of the Proxy Statement. This Amendment should be read in conjunction with the disclosures contained in the Proxy Statement, which should be read in its entirety. To the extent that the information set forth herein differs from or updates information contained in the Proxy Statement, the information set forth herein shall supersede or supplement the information in the Proxy Statement. All page references are to pages in the Proxy Statement, and terms used below, unless otherwise defined in this Amendment, have the meanings set forth in the Proxy Statement. Except as described above, no changes have been made to the Proxy Statement, and this Amendment does not modify, amend or update any of the other information contained in the Proxy Statement. For clarity, new text within the restated disclosure from the Proxy Statement is presented in bold and underlined text and deletions to the previous disclosure are presented in strikethrough.

     

    As of the date hereof, the Company has received stockholder votes on Proposal 1 and Proposal 2. Unless stockholders who have already voted on Proposal 1 and Proposal 2 revoke their existing proxy and submit a new proxy, all such stockholder votes received as of the date of this Amendment on Proposal 1 and Proposal 2 will be unaffected by this Amendment. All stockholders are entitled and encouraged to revoke any existing proxy and resubmit voting instructions. The Board of Directors of the Company, including the Independent Directors, unanimously recommends that all stockholders vote “FOR” each of the proposals, including the election of the nominees for director in the Proxy Statement, as amended. The election of a director requires a plurality of the votes cast at the 2025 Annual Meeting of Stockholders. Because a director is elected by a plurality of the votes cast at the 2025 Annual Meeting of Stockholders, votes to withhold authority will have no effect on Proposal 1 or Proposal 2.

     

    You may revoke your existing proxy by (1) delivering a written revocation notice that is received prior to the 2025 Annual Meeting of Stockholders to the Secretary of Horizon Technology Finance Corporation at 312 Farmington Avenue, Farmington, CT 06032; (2) resubmitting voting instructions via the Internet voting site; (3) obtaining, properly completing and submitting another proxy card that is dated later than the original proxy card and is received before the conclusion of voting at the 2025 Annual Meeting of Stockholders; (4) resubmitting voting instructions by calling the telephone number on your proxy card; or (5) attending the 2025 Annual Meeting of Stockholders and voting in person. If your shares are held in “street name” by your broker, bank or other nominee, you must follow the instructions you receive from such nominee in order to revoke your voting instructions. Attending the 2025 Annual Meeting of Stockholders does not revoke your proxy unless you also vote or submit a later-dated proxy at the 2025 Annual Meeting of Stockholders.

     

     

     

     

    Supplemental Disclosures.

     

    The following disclosure revises the disclosure in the Proxy Statement under the heading “PROPOSAL 1: ELECTION OF DIRECTORS” and is supplemented as follows:

     

    PROPOSAL 1: ELECTION OF DIRECTORS

     

    In accordance with the Company’s certificate of incorporation and bylaws, the Board currently has eight directors. Directors are divided into three classes with each class serving staggered three-year terms. At each annual meeting of stockholders, the successors to the class of directors whose terms expire at such meeting will be elected to hold office for a term expiring at the annual meeting of stockholders held in the third year following their year of election. After this election, the terms of Class I, Class II and Class III directors will expire at the annual meeting of stockholders to be held in 2026, 2027 and 2028, respectively. Each director will hold office for the term to which he or she is elected or until his or her successor is duly elected and qualified. Mr. Bottiglieri and Mr. Michaud are Class I directors, whose terms will expire at the 2026 annual meeting of stockholders.1 Mr. Balkin, Mr. Mahoney and Ms. Sarsynski are Class II directors, whose terms will expire at the 2027 annual meeting of stockholders. Mr. Goodman, Mr. Pomeroy and Mr. Savage are Class III directors and are up for re-election at the Meeting. In addition, Ms. O’Connor is nominated to serve as a Class I director and is up for election at the Meeting.

     

    . . .

     

     


    1 In accordance with the Retirement Policy (as defined below), subject to any extension or waiver approved by a majority of the Board, Mr. Bottiglieri is expected to tender his resignation as a director no later than December 31, 2025. Notwithstanding such tender, the Board may request that Mr. Bottiglieri continue to serve beyond such date.

     

    As disclosed in the Current Report on Form 8-K filed on May 15, 2025, Mr. Michaud announced his retirement as President of the Company, effective as of June 5, 2025 immediately following the Meeting. He also announced his resignation as a director of the Company, effective as of June 5, 2025 immediately following the Meeting, in order to ensure compliance with Section 15(f) of the 1940 Act, which includes a requirement that at least 75% of the members of the Board not be “interested persons” (as defined in Section 2(a)(19) of the 1940 Act) of the Company following the consummation of change of control transactions involving the Advisor. In addition, Mr. Michaud will retire as President of the Advisor, effective as of June 5, 2025 immediately following the Meeting.

     

    2

     

     

     

    The following disclosure revises the disclosure in the Proxy Statement under the heading “PROPOSAL 1: ELECTION OF DIRECTORS—Information About the Nominees and Directors—Nominees for Class III Directors” and is supplemented as follows:

     

    Nominees for Class III Directors

     

    Name, Address and Age(1)

     

    Position(s)

    Held with

    the

    Company

     

    Term of

    Office and

    Length of

    Time

    Served

     

    Principal

    Occupation(s)

    During the Past 5 Years

     

    Other

    Public Company

    Directorships

    Held by Director

    or Nominee for

    Director During

    the Past

    5 Years(2)

                     

    Independent Director

                   

    Jonathan J. Goodman (53)

     

    Director; Nominee

     

    Class III Director since June 2023; Term expires 2025

     

    Founder and Managing Director since June 2018 of Qiviut Capital LP.

     

    None.

                     

    Interested Director

                   

    Robert D. Pomeroy, Jr. (74)(3), (6)

     

    Chairman of the Board; Director; Chief Executive Officer; Nominee

     

    Class III Director since March 2010; Term expires 2025

     

    Chief Executive Officer since March 2010 and Chairman of the Board since July 2010 of the Company; Chief Executive Officer since May 2003, Managing Member from May 2003 to June 2023 of the Advisor.

     

    None.

                     

    Independent Director

                   

    Joseph J. Savage (72)

     

    Director; Nominee

     

    Class III Director since March 2016; Term expires 2025

     

    Retired since 2017.

     

    None.

     

    3

     

     

     

    The following disclosure revises the disclosure in the Proxy Statement under the heading “PROPOSAL 1: ELECTION OF DIRECTORS—Information About the Nominees and Directors—Class I Directors” and is supplemented as follows:

     

    Class I Directors

    (continuing directors not up for re-election at the Meeting)

     

    Name, Address and Age(1)

     

    Position(s)

    Held with

    the

    Company

     

    Term of

    Office and

    Length of

    Time

    Served

     

    Principal

    Occupation(s)

    During the Past 5 Years

     

    Other

    Public Company

    Directorships

    Held by Director

    or Nominee for

    Director During

    the Past

    5 Years(2)

                     

    Independent Director

                   

    James J. Bottiglieri (69)(4)

     

    Director

     

    Class I Director since July 2010; Term expires 2026

     

    Retired since 2013.

     

    Director since December 2005 of Compass Group Diversified Holdings LLC (NYSE: CODI).

                     

    Interested Director

                   

    Gerald A. Michaud (72)(3), (7)

     

    Director; President

     

    Class I Director since March 2014; Class II Director from March 2010 through March 2014; Term expires 2026

     

    President and Director since March 2010 of the Company; President since May 2003, Managing Member from May 2003 to June 2023 of the Advisor.

     

    None.

     

    4

     

     

     

    The following disclosure revises the disclosure in the Proxy Statement under the heading “PROPOSAL 1: ELECTION OF DIRECTORS—Information About the Nominees and Directors—Class II Directors” and is supplemented as follows:

     

    Class II Directors

    (continuing directors not up for re-election at the Meeting)

     

    Name, Address and Age(1)

     

    Position(s)

    Held with

    the

    Company

     

    Term of

    Office and Length of Time Served

     

    Principal

    Occupation(s)

    During the Past 5 Years

     

    Other

    Public Company

    Directorships

    Held by Director

    or Nominee for

    Director During the Past 5 Years(2)

                     

    Independent Director

                   

    Michael Balkin (66)(8)

     

    Director

     

    Class II Director since June 2023; Term expires 2027

     

    Advisor since February 2025, Director until October 2024 of Innventure, Inc. (INV); Director since October 2024 of Affluence Corporation; Advisor since June 2023 to OptimizeRX Corporation; Advisor since April 2023 to P3 Health Partners Inc.; Financial AdvisorPrincipal since 20222023 to the Rail-Splitter Micro Cap Rebound Fund; Chief Executive Officer since 2021 of MPB Enterprises; Advisor since 2021 to Wasson Enterprise LLC; Advisor from June 2023 to April 2024 of OptimizeRX Corporation; Chief Executive Officer from January 2021 to December 31, 2021 of Foresight Acquisition Corp; Chairman and Director since November 2013 of Performance Health Systems, LLC.

     

    None.